Urokinase-dependent proteolysis in cultured colon cancer is directed by its receptor.
Hollas
W
W
Pharmacology Department, Baylor College of Medicine, Houston, Texas.
Boyd
D
D
D003110:Colonic Neoplasms / Q000378:metabolism* / Q000473:pathology; D005109:Extracellular Matrix / Q000473:pathology; D006801:Humans; D007797:Laminin / Q000378:metabolism; D009361:Neoplasm Invasiveness; D010447:Peptide Hydrolases / Q000378:metabolism; D010958:Plasminogen / Q000378:metabolism; D015849:Plasminogen Inactivators / Q000494:pharmacology; D011956:Receptors, Cell Surface / Q000378:metabolism / Q000502:physiology*; D055293:Receptors, Urokinase Plasminogen Activator; D014407:Tumor Cells, Cultured; D014568:Urokinase-Type Plasminogen Activator / Q000378:metabolism*
D007797:Laminin; C524898:PLAUR protein, human; D015849:Plasminogen Inactivators; D011956:Receptors, Cell Surface; D055293:Receptors, Urokinase Plasminogen Activator; D010958:Plasminogen; D010447:Peptide Hydrolases; D014568:Urokinase-Type Plasminogen Activator